Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
34474
Description
Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance; ODM derived from: https://clinicaltrials.gov/show/NCT01191099
Link
https://clinicaltrials.gov/show/NCT01191099
Keywords
Versions (2)
- 1/17/19 1/17/19 -
- 5/27/19 5/27/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT01191099
Eligibility Prostate Cancer NCT01191099
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01191099
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of zurich
boolean
ID.2
Item
written informed consent
boolean
ID.3
Item
metastatic prostate cancer
boolean
ID.4
Item
contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
boolean
ID.5
Item
severe heart or lung disease
boolean
ID.6
Item
severe liver or kidney dysfunction
boolean
ID.7
Item
severe stridor
boolean
ID.8
Item
distant metastases
boolean
ID.9
Item
concurrent treatment for other malignant disease
boolean
ID.10
Item
prior hormonal therapy or radiotherapy
boolean